From: Change in condom and other barrier method use during and after an HIV prevention trial in Zimbabwe
Change in condom use and use of any barrier method at last sex, among condom group participants (n = 420) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Last MIRA Follow-up Visit | Â | Last FU visit | Post-trial visit | AOR | Lower limit | Upper limit | p value | ||
 |  | n | % | n | % |  |  |  |  |
model 1 | Condom use at last sex | 363 | 86.43 | 283 | 67.38 | Â | Â | Â | Â |
 | Visit type* |  |  |  |  | 0.20 | 0.12 | 0.33 | < 0.0001 |
 | Time since trial exit |  |  |  |  | 0.95 | 0.88 | 1.03 | 0.228 |
 | Number of MIRA visits |  |  |  |  | 1.01 | 0.84 | 1.22 | 0.8899 |
model 2 | Any barrier method | 374 | 89.05 | 312 | 74.29 | Â | Â | Â | Â |
 | Visit type* |  |  |  |  | 0.21 | 0.12 | 0.35 | < 0.0001 |
 | Time since trial exit |  |  |  |  | 0.96 | 0.88 | 1.05 | 0.347 |
 | Number of MIRA visits |  |  |  |  | 0.93 | 0.75 | 1.16 | 0.5293 |
MIRA Enrolment Visit | Â | Enrolment visit | Post-trial visit | AOR | Lower limit | Upper limit | p value | ||
---|---|---|---|---|---|---|---|---|---|
 |  | n | % | n | % |  |  |  |  |
model 1 | Condom use at last sex | 310 | 73.81 | 283 | 67.38 | Â | Â | Â | Â |
 | Visit type** |  |  |  |  | 0.66 | 0.46 | 0.93 | 0.0196 |
 | Time since trial exit |  |  |  |  | 0.96 | 0.90 | 1.02 | 0.1824 |
 | Number of MIRA visits |  |  |  |  | 1.07 | 0.91 | 1.25 | 0.4349 |
model 2 | Any barrier method | 323 | 76.9 | 312 | 74.29 | Â | Â | Â | Â |
 | Visit type** |  |  |  |  | 0.83 | 0.58 | 1.19 | 0.3178 |
 | Time since trial exit |  |  |  |  | 0.96 | 0.90 | 1.02 | 0.2077 |
 | Number of MIRA visits |  |  |  |  | 1.02 | 0.87 | 1.20 | 0.7732 |
Change in diaphragm, condom use and use of any barrier method at last sex, among diaphragm group participants (n = 381) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Last MIRA Follow-up Visit | Â | Last FU visit | Post-trial visit | AOR | Lower limit | Upper limit | p value | ||
 |  | n | % | n | % |  |  |  |  |
model 1 | Diaphragm at last sex | 303 | 79.53 | 192 | 50.39 | Â | Â | Â | Â |
 | Visit type* |  |  |  |  | 0.18 | 0.12 | 0.28 | < 0.0001 |
 | Time since trial exit |  |  |  |  | 0.95 | 0.89 | 1.01 | 0.1058 |
 | Number of MIRA visits |  |  |  |  | 1.28 | 1.09 | 1.49 | 0.0024 |
model 2 | Condom use at last sex | 231 | 60.63 | 214 | 56.17 | Â | Â | Â | Â |
 | Visit type* |  |  |  |  | 0.77 | 0.55 | 1.09 | 0.1425 |
 | Time since trial exit |  |  |  |  | 1.03 | 0.96 | 1.10 | 0.4054 |
 | Number of MIRA visits |  |  |  |  | 1.26 | 1.07 | 1.49 | 0.0062 |
model 3 | Any barrier method | 357 | 93.7 | 285 | 74.8 | Â | Â | Â | Â |
 | Visit type* |  |  |  |  | 0.15 | 0.08 | 0.27 | < 0.0001 |
 | Time since trial exit |  |  |  |  | 0.93 | 0.86 | 1.00 | 0.0593 |
 | Number of MIRA visits |  |  |  |  | 1.29 | 1.07 | 1.55 | 0.0072 |
MIRA Enrolment Visit | Â | Enrolment visit | Post-trial visit | AOR | Lower limit | Upper limit | p value | ||
---|---|---|---|---|---|---|---|---|---|
 |  | n | % | n | % |  |  |  |  |
model 1 | Condom use at last sex | 259 | 67.98 | 214 | 56.17 | Â | Â | Â | Â |
 | Visit type** |  |  |  |  | 0.55 | 0.39 | 0.76 | 0.0004 |
 | Time since trial exit |  |  |  |  | 0.99 | 0.94 | 1.05 | 0.7865 |
 | Number of MIRA visits |  |  |  |  | 1.18 | 1.03 | 1.36 | 0.0153 |
model 2 | Any barrier method | 267 | 70.08 | 285 | 74.8 | Â | Â | Â | Â |
 | Visit type** |  |  |  |  | 1.33 | 0.93 | 1.89 | 0.1134 |
 | Time since trial exit |  |  |  |  | 0.96 | 0.90 | 1.02 | 0.1764 |
 | Number of MIRA visits |  |  |  |  | 1.16 | 1.00 | 1.34 | 0.0553 |